ISDA: 1N94

Deposition Date 2002-11-22

Release Date 2003-01-07

Last Version Date 2024-12-25

Entry Detail

PDB ID:

1N94

Keywords:

TRANSFERASE

Title:

Aryl Tetrahydropyridine Inhbitors of Farnesyltransferase: Glycine, Phenylalanine and Histidine Derivates

Biological Source:

Source Organism:

Rattus norvegicus (Taxon ID: 10116)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.50 Å

R-Value Free:

0.29

R-Value Work:

0.29

Space Group:

P 61

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase alpha subunit
Gene (Uniprot):Fnta
Chain IDs:A
Chain Length:315
Number of Molecules:1
Biological Source:Rattus norvegicus

UniProt ID:Q04631 Pfam ID:PF01239 EC:2.5.1.58

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase beta subunit
Gene (Uniprot):Fntb
Chain IDs:B
Chain Length:397
Number of Molecules:1
Biological Source:Rattus norvegicus

UniProt ID:Q02293 Pfam ID:PF00432 EC:2.5.1.58

Ligand Molecules

HFP

TIN

Primary Citation

Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives.

Gwaltney II, S.L, O'Connor, S.J, Nelson, L.T, Sullivan, G.M, Imade, H, Wang, W, Hasvold, L, Li, Q, Cohen, J, Gu, W.Z, Tahir, S.K, Bauch, J, Marsh, K, Ng, S.C, Frost, D.J, Zhang, H, Muchmore, S, Jakob, C.G, Stoll, V, Hutchins, C, Rosenberg, S.H, Sham, H.L.Show

Bioorg.Med.Chem.Lett. 13 1359 1362 (2003)

PMID: 12657282 DOI: 10.1016/S0960-894X(03)00095-7

Abstact

Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures